Entrada Therapeutics, Inc. ($TRDA)
WENTWORTH KORY JAMES โ Chief Financial Officer
Shares
66,600
Price
$0.00
Total Value
$0.00
Nearby Earnings
Feb 26, 2026
EPS:Est: -1.32
Revenue:Est: $7.41M
Transaction Details
| Insider | WENTWORTH KORY JAMES |
|---|---|
| Title | Chief Financial Officer |
| Transaction Date | Mar 1, 2026 |
| Expiration Date | Mar 1, 2036 |
| Transaction Code | A Grant/Award |
| Acquired/Disposed | Acquired |
| Security | Stock Option (Right to Buy) |
| Derivative | Yes |
| Direct/Indirect | Direct |
| Filing Date | Mar 3, 2026 |
| Shares Purchased | 66,600 |
| Price per Share | $0.00 |
| Total Value | $0.00 |
| Shares Owned After | 66,600 |
| Derivative | Derivative |
| Accession Number | 0001725663-26-000001 |
| Document | View SEC Filing |